相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer
Tarek A. Bismar et al.
HISTOPATHOLOGY (2012)
A travel guide to Cytoscape plugins
Rintaro Saito et al.
NATURE METHODS (2012)
PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer
Tarek A. Bismar et al.
BJU INTERNATIONAL (2011)
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome
Agnes Marije Hoogland et al.
BJU INTERNATIONAL (2011)
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis
Anna Dahlman et al.
MODERN PATHOLOGY (2011)
Cysteine-Rich Secretory Protein-3 (CRISP3) Is Strongly Up-Regulated in Prostate Carcinomas with the TMPRSS2-ERG Fusion Gene
Franclim R. Ribeiro et al.
PLOS ONE (2011)
Syndecan-1 expression in prostate cancer and its value as biomarker for disease progression
Fadi Brimo et al.
BJU INTERNATIONAL (2010)
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
A. H. M. Reid et al.
BRITISH JOURNAL OF CANCER (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Anuradha Gopalan et al.
CANCER RESEARCH (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Fascin Regulates Prostate Cancer Cell Invasion and Is Associated with Metastasis and Biochemical Failure in Prostate Cancer
Andrew D. Darnel et al.
CLINICAL CANCER RESEARCH (2009)
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
Bo Han et al.
MODERN PATHOLOGY (2009)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
Association of cysteine-rich secretory protein 3 and β-microseminoprotein with outcome after radical prostatectomy
Anders S. Bjartell et al.
CLINICAL CANCER RESEARCH (2007)
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists
Da Wei Huang et al.
GENOME BIOLOGY (2007)
Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland
A Bjartell et al.
PROSTATE (2006)
Detection of prostate cancer by α-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy
BM Carswell et al.
HISTOPATHOLOGY (2006)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma -: A gene expression analysis on total and microdissected prostate tissue
T Ernst et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
分享论文
